Program

A paper version of the Participant Guide will be available at the site of the Forum, but you can already consult it to get ready to the event. Click here to download it.

7h	Reception and registration
8h30	Opening speech Juan Roberto Iglesias, President and Chief Executive Officer of INESSS
8h50	Presentation of the day's Agenda Paul L'Archevêque, Senior Partner, CapCOGITO
9h00	Speech by Québec Internationnal, Health Innovation Week Partner Carl Viel, President and Chief Executive Officer, Québec International
9h10	Opening Conference Évaluer pour mieux innover: l'INESSS et son écosystème Reiner Banken, Advisor to the CEO of INESSS, Alliances and Networks
9h35	Panel 1 - Différents acteurs, différentes perspectives...des enjeux communs? Gaétan Barrette, President, Fédération des médecins spécialistes du Québec Alain Boisvert, Vice-President, Market Access and Public Affairs, Bristol-Myers Squibb Canada Diane Côté, President and Chief Executive Officer, Quebec Research and Innovation Consortium in Medical Technologies, MEDTEQ Vincent Dumez, Director, Bureau de l'expertise patient partenaire, University of Montreal Louise Lavergne, President and Chief Executive Officer, Institut de réadaptation en déficience physique de Québec Marc Rhainds, Medical and Scientific Manager of Health Technology Assessment activities, CHU de Québec
10h35	Refreshment Break
10h55	Workshop - Les enjeux: Débattons, organisons et priorisons François Bastien, General Manager, Health, Public and Parapublic markets,Telus Christian Bellemare, Coordinator, Health Technology Assessment Unit,CHUS Hôtel-Dieu Sylvie Bouchard, Scientific Director, Follow-up and Optimal Use, INESSS Pierre Dagenais, Director, Directorate of Quality and Method Support, INESSS Kim Furlong, Director, Government Affairs, Amgen Benoit Larose, Vice President, MEDEC, Québec France Mignault, Director, Government Affairs, Québec, Janssen Gilles Pineau, Coordinator, Oncology Assessment Unit, INESSS
12h05	Plenary session
12h35	Lunch Conference Revue d'initiatives d'avant-garde internationales François Meyer, Advisor to the CEO of France Haute Autorité de Santé , International Relations
14h05	Workshop - Les pistes de solution: Débattons, proposons, innovons Stéphane Ahern, Internist-intensivist, Maisonneuve-Rosemont Hospital and Chair of INESSS Comité scientifique permanent de l'évaluation des médicaments aux fins d'inscription (CSEMI) Dan Cooper, Principal Scientific Advisor- Pharmacoeconomics, INESSS Michelle Laflamme, President and Chief Executive Officer, Émovi Luigi Lepanto, Director, Health Technology Assessment Unit, CHUM Marc Osborne, Director, Government Relations and Health Policy Oncology Division, Hoffman-LaRoche Sophie Rochon, Senior Manager, Patient Access and Health Policy, Pfizer Jean Rousseau, Business Unit Director, Covidien Éric St-Gelais, Conseiller en orientation et coordination de la recherche et de l'innovation, MSSS
15h15	Plenary session
15h45	Refreshment Break
16h	Panel Discussion - Différents acteurs, différentes perspectives...des solutions en synergie? Luc Castonguay, Sous-ministre adjoint à la Direction générale de la planification, de la performance et de la qualité, Ministère de la Santé et des Services sociaux du Québec Juan Roberto Iglesias, President and Chief Executive Officer of INESSS Paul Lirette, President, GlaxoSmithKline Canada Teresa Mattarelli, Vice-President and General Manager, Covidien Canada
16h45	Closing Conference Évaluer pour mieux innover...place à l'action Véronique Déry, Chief Scientific Advisor, INESSS
17h05	Closing Speech Réjean Hébert, ministre de la Santé et des Services sociaux et ministre Responsable des Aînés
17h30	Cocktail

Please note that all speeches and workshops will be in French, and simultaneous translation to English will be provided.